English | Spanish
ecancer
Supporting oncology professionals through education
Login Register

The content on this site is intended for healthcare professionals only

  • Home
  • News
  • Journal
  • Video
  • elearning
  • Events
  • Conferences
  • About us
Breast Prostate & urology Lung & pleura Colorectal & gastro Melanoma & skin Head & neck Ovary & gynaecology Bone Brain & nervous system Haematology oncology Hepatobiliary pancreatic Paediatric Neuroendocrine Sarcomas

News

  • Latest news
  • Sign up for news alerts
  • Submit your news

Explore

  • Bone
  • Brain & nervous system
  • Breast
  • Colorectal & gastro
  • Haematology oncology
  • Head & neck
  • Hepatobiliary pancreatic
  • Lung & pleura
  • Melanoma & skin
  • Neuroendocrine
  • Ovary & gynaecology
  • Paediatric
  • Prostate & urology
  • Sarcomas

Journal information

  • Journal home
  • Charges
  • Editorial board
  • Founding editors
  • Editor-in-chief
  • Contact us

Author information

  • Submit article
  • Author guidelines
  • Editorial policies
  • Copyright information
  • Why publish with us

Reviewer information

  • Reviewer guidelines

Memberships

Open Access Scholarly Publishers Association Crossref Healthcare Information For All Commitee On Publication Ethics

Videos

  • Recent videos
  • Sign up

Explore

  • Bone
  • Brain & nervous system
  • Breast
  • Colorectal & gastro
  • Haematology oncology
  • Head & neck
  • Hepatobiliary pancreatic
  • Lung & pleura
  • Melanoma & skin
  • Neuroendocrine
  • Ovary & gynaecology
  • Paediatric
  • Prostate & urology
  • Sarcomas

Conferences

  • Latest conferences
  • Sign up for latest coverage
  • Submit your event

About ecancer

  • About ecancer
  • Our founders
  • Funding statement
  • Contact us
  • Home
  • News
  • Journal
  • Video
  • elearning
  • Events
  • Conferences
  • About us
Breast Prostate & urology Lung & pleura Colorectal & gastro Melanoma & skin Head & neck Ovary & gynaecology
+ -
Bone Brain & nervous system Haematology oncology Hepatobiliary pancreatic Paediatric Neuroendocrine Sarcomas

ecancer and the City Cancer Challenge have formed an educational collaboration. Learners who are part of the City Cancer Challenge's project can access additional education provided by them.

Please login or register. Then you can use this button to confirm you are part of this project.
Register for free Already have an account? Login
Videos [1386]
News [2583]
Articles [24]
Editorials [0]
Conferences [149]
elearning [15]
Cediranib and chemo combo improves PFS for metastatic cervical cancer
Dr Raymond 'Paul' Symonds - University Hospital of Leicester, Leicester, UK
Cediranib and chemo combo improves PFS for metastatic cervical cancer ( Dr Raymond 'Paul' Symonds - University Hospital of Leicester, Leicester, UK )
28 Sep 2014
Phase III trial results raise questions about the future of lung cancer...
Prof Johan Vansteenkiste - University Hospital Leuven, Leuven, Belgium
Phase III trial results raise questions about the future of lung cancer vaccination ( Prof Johan Vansteenkiste - University Hospital Leuven, Leuven, Belgium )
28 Sep 2014
Little benefit for gefitinib-resistant lung cancer when continuing the drug...
Dr Tony Mok - The Chinese University of Hong Kong, Shatin, China
Little benefit for gefitinib-resistant lung cancer when continuing the drug with chemotherapy ( Dr Tony Mok - The Chinese University of Hong Kong, Shatin, China )
28 Sep 2014
Pertuzumab adds 16 months survival benefit to trastuzumab plus chemotherapy for...
Dr Sandra Swain - Washington Cancer Institute, Washington, USA
Pertuzumab adds 16 months survival benefit to trastuzumab plus chemotherapy for HER2-positive metastatic breast cancer ( Dr Sandra Swain - Washington Cancer Institute, Washington, USA )
28 Sep 2014
Adding cediranib to chemo improves PFS for metastatic cervical cancer
Dr Paul Symonds - University Hospital of Leicester, Leicester, UK
Adding cediranib to chemo improves PFS for metastatic cervical cancer ( Dr Paul Symonds - University Hospital of Leicester, Leicester, UK )
28 Sep 2014
Rare cancers and the difficulties in making clinical decisions
Dr Paolo Casali - National Tumour Institute, Milan, Italy
Rare cancers and the difficulties in making clinical decisions ( Dr Paolo Casali - National Tumour Institute, Milan, Italy )
27 Sep 2014
Anamorelin improves appetite and body mass in non-small cell lung cancer with...
Dr David Currow - Flinders University, Adelaide, Australia
Anamorelin improves appetite and body mass in non-small cell lung cancer with cancer anorexia-cachexia ( Dr David Currow - Flinders University, Adelaide, Australia )
27 Sep 2014
Rolapitant reduces nausea and vomiting associated with cisplatin-based...
Dr Bernardo Leon Rapoport - The Medical Oncology Centre, Johannesburg, South...
Rolapitant reduces nausea and vomiting associated with cisplatin-based chemotherapy ( Dr Bernardo Leon Rapoport - The Medical Oncology Centre, Johannesburg, South Africa )
27 Sep 2014
Second-line afatinib significantly improves PFS in metastatic head and neck...
Dr Jean-Pascal Machiels - Cliniques Universitaires Saint-Luc, Brussels, Belgium
Second-line afatinib significantly improves PFS in metastatic head and neck cancer ( Dr Jean-Pascal Machiels - Cliniques Universitaires Saint-Luc, Brussels, Belgium )
27 Sep 2014
Optimising metastic renal cell carcinoma (mRCC): Treatment lessons from the...
Dr Thomas Hutson - Baylor University Medical Center, Dallas, USA
Optimising metastic renal cell carcinoma (mRCC): Treatment lessons from the real world: Introduction ( Dr Thomas Hutson - Baylor University Medical Center, Dallas, USA )
23 Sep 2014
Additional treatment options impact first-line treatment of mRCC: No
Prof Stéphan Oudard - Hôpital Européen Georges Pompidou, Paris, France
Additional treatment options impact first-line treatment of mRCC: No ( Prof Stéphan Oudard - Hôpital Européen Georges Pompidou, Paris, France )
23 Sep 2014
Current treatment options in mRCC
Dr Thomas Hutson - Baylor University Medical Center, Dallas, USA
Current treatment options in mRCC ( Dr Thomas Hutson - Baylor University Medical Center, Dallas, USA )
23 Sep 2014
<1...979899100101...116>

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation

  • Contact
  • Projects
  • Cookie Policy
  • Terms of Use
  • Desktop Site
  • Privacy Policy
© 2025 ecancer, all rights reserved
UK registered charity number: 1176307
Back to Top